Update to "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors"

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e534-e535
JournalThe oncologist
Volume27
Issue number6
DOIs
StatePublished - Jun 8 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this